BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19305997)

  • 1. Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis?
    Al-Dasooqi N; Gibson RJ; Bowen JM; Keefe DM
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):1-9. PubMed ID: 19305997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases and gut toxicity following cytotoxic cancer therapy.
    Al-Dasooqi N
    Curr Opin Support Palliat Care; 2014 Jun; 8(2):164-9. PubMed ID: 24752198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat.
    Al-Dasooqi N; Gibson RJ; Bowen JM; Logan RM; Stringer AM; Keefe DM
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1244-56. PubMed ID: 20682600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.
    Logan RM; Stringer AM; Bowen JM; Yeoh AS; Gibson RJ; Sonis ST; Keefe DM
    Cancer Treat Rev; 2007 Aug; 33(5):448-60. PubMed ID: 17507164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment.
    Stringer AM; Gibson RJ; Bowen JM; Logan RM; Yeoh AS; Keefe DM
    J Support Oncol; 2007 Jun; 5(6):259-67. PubMed ID: 17624050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regimen-related gastrointestinal toxicities in cancer patients.
    Sonis ST
    Curr Opin Support Palliat Care; 2010 Mar; 4(1):26-30. PubMed ID: 20040879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation.
    Okamoto T; Akuta T; Tamura F; van Der Vliet A; Akaike T
    Biol Chem; 2004 Nov; 385(11):997-1006. PubMed ID: 15576319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptides 1 and 2: intestinal hormones implicated in the pathophysiology of mucositis.
    Kissow H
    Curr Opin Support Palliat Care; 2015 Jun; 9(2):196-202. PubMed ID: 25872118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced mucositis is associated with changes in proteolytic pathways.
    Leblond J; Le Pessot F; Hubert-Buron A; Duclos C; Vuichoud J; Faure M; Breuillé D; Déchelotte P; Coëffier M
    Exp Biol Med (Maywood); 2008 Feb; 233(2):219-28. PubMed ID: 18222977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal mucositis: mechanisms and management.
    Keefe DM
    Curr Opin Oncol; 2007 Jul; 19(4):323-7. PubMed ID: 17545794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases.
    Stringer AM; Al-Dasooqi N; Bowen JM; Tan TH; Radzuan M; Logan RM; Mayo B; Keefe DM; Gibson RJ
    Support Care Cancer; 2013 Jul; 21(7):1843-52. PubMed ID: 23397098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New pharmacotherapy options for chemotherapy-induced alimentary mucositis.
    Wardill HR; Bowen JM; Gibson RJ
    Expert Opin Biol Ther; 2014 Mar; 14(3):347-54. PubMed ID: 24387716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced mucositis: the role of mucin secretion and regulation, and the enteric nervous system.
    Thorpe D; Stringer A; Butler R
    Neurotoxicology; 2013 Sep; 38():101-5. PubMed ID: 23827812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of high-dose enteral glutamine on the incidence and severity of mucositis in paediatric oncology patients.
    Ward E; Smith M; Henderson M; Reid U; Lewis I; Kinsey S; Allgar V; Bowers D; Picton SV
    Eur J Clin Nutr; 2009 Jan; 63(1):134-40. PubMed ID: 17728695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal mucositis: focus on the treatment of the effects of chemotherapy and radiotherapy on the rectum.
    Zur E
    Int J Pharm Compd; 2012; 16(2):117-24. PubMed ID: 23050323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A time for hope: promising advances in the management of anemia, neutropenia, thrombocytopenia, and mucositis.
    Kurtin SE
    J Support Oncol; 2007 Apr; 5(4 Suppl 2):85-8. PubMed ID: 17550057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe mucositis: how can nutrition help?
    Keefe DM; Rassias G; O'Neil L; Gibson RJ
    Curr Opin Clin Nutr Metab Care; 2007 Sep; 10(5):627-31. PubMed ID: 17693748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of treatment-induced mucosal barrier injury.
    Blijlevens NM
    Curr Opin Oncol; 2005 Nov; 17(6):605-10. PubMed ID: 16224241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of vitamin "E" in the treatment of oral mucositis in children receiving chemotherapy.
    El-Housseiny AA; Saleh SM; El-Masry AA; Allam AA
    J Clin Pediatr Dent; 2007; 31(3):167-70. PubMed ID: 17550040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Bovine Immunoglobulin for Chemotherapy-Induced Gastrointestinal Mucositis.
    Arikapudi S; Rashid S; Al Almomani LA; Treece J; Baumrucker SJ
    Am J Hosp Palliat Care; 2018 May; 35(5):814-817. PubMed ID: 29020798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.